Clinical Trials on Glabellar Crease in United Kingdom

Total 7463 results

Nancy Lin, MD
Bayer; Brigham and Women's Hospital; Breast Cancer Research Foundation

Terminated

ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases

Breast Cancer | CNS Disease

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts

Breast Diseases

United States
Mayo Clinic

Completed

Histology of Functional Density in Postmenopausal Breast

Breast Cancer | Dense Breasts

United States
University of Texas Southwestern Medical Center
Cancer Prevention Research Institute of Texas

Completed

Promoting Activity in Cancer Survivors (PACES)

Breast Cancer | Physical Activity

United States
Abramson Cancer Center of the University of Pennsylvania

Completed

Assessment of Cancer Concerns at the End of Treatment (ACE)

Breast Cancer(BC) Survivors

United States
Mayo Clinic

Completed

Histology of Functional Density in Premenopausal Breast

Breast Cancer | Dense Breasts

United States
AstraZeneca

Completed

Open Label Arimidex in Gynecomastia

Gynecomastia

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...

Completed

Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors

Stage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditions

United States
Sanofi

Terminated

Phase 2 Window Study of SAR439859 (Amcenestrant) Versus Letrozole in Post-menopausal Patients With ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer (AMEERA-4)

Breast Cancer

Belgium, United States, France, Italy, Puerto Rico, Spain, Ukraine, Japan, Russia
AstraZeneca

Active, not recruiting

Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC (CAPItello-290)

Triple Negative Breast Neoplasms

United States, Sweden, Taiwan, Thailand, Vietnam, France, United Kingdom, Brazil, Hungary, India, Mexico, Peru, Philippines, Poland, China, Malaysia, Canada, Spain, Japan, Portugal, South Africa, Argentina, Greece, Slovakia, Czechia, Saudi... and more
Bristol-Myers Squibb

Completed

Study of MDX-010 in Stage IV Breast Cancer

Adenocarcinoma | Breast Cancer

United States
Pfizer
Arvinas Estrogen Receptor, Inc.

Active, not recruiting

Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast Cancer (VERITAC-3)

Breast Cancer

United States, Spain, China, Japan, Australia, Italy, Hungary, Brazil, Switzerland, Slovakia
Calithera Biosciences, Inc

Completed

Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer

Breast Cancer

United States, Belgium, France
National Cancer Institute (NCI)

Completed

Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2

Breast Cancer

United States, South Africa
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer

Stage I Breast Cancer | Stage II Breast Cancer | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage III Colorectal Cancer AJCC v7 | Stage IIIA Colorectal Cancer AJCC v7 | Stage IIIB Colorectal Cancer... and other conditions

United States
Memorial Sloan Kettering Cancer Center
Gateway for Cancer Research

Active, not recruiting

The Effect of Acupuncture on Nerve Pain Caused by Taxane (Chemotherapy) Treatment

Breast Cancer | Taxane-Induced Peripheral Neuropathy

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Suspended

Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)

Anatomic Stage IV Breast Cancer AJCC v8 | Chemotherapy-Induced Peripheral Neuropathy | Metastatic Breast Carcinoma

United States
University of California, San Diego

Completed

Reach for Health Study: Obesity-related Mechanisms and Mortality in Breast Cancer Survivors

Breast Neoplasms

United States
University of Southern California
National Institutes of Health (NIH)

Active, not recruiting

In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors

Soft Tissue Sarcoma | Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Melanoma | Merkel Cell Carcinoma | Unresectable Melanoma | Basal Cell Carcinoma | Unresectable Breast Carcinoma | Bone Sarcoma | Sarcoma,Soft Tissue | Metastatic Breast Carcinoma | Cutaneous... and other conditions

United States
University of California, San Francisco
Mount Zion Health Fund

Completed

Incorporating ePrognosis for the Encouragement of Smarter Screening for Breast and Colorectal Cancer in Older Adults

Breast Carcinoma | Colorectal Carcinoma

United States
Philip Schaner
National Cancer Institute (NCI)

Terminated

EPR Tumor Oximetry With CE India Ink

Melanoma | Head and Neck Neoplasms | Carcinoma, Squamous Cell | Carcinoma, Basal Cell | Breast Neoplasm | Neoplasms, Malignant | Skin Neoplasm

United States
Duke University
National Cancer Institute (NCI)

Completed

Biological Therapy in Treating Patients With Advanced Cancer

Breast Cancer | Gastric Cancer | Ovarian Cancer

United States
Target Health Inc.

Unknown

Efficacy and Safety of Dignicap System for Preventing Chemotherapy Induced Alopecia

Breast Cancer | Chemotherapy Adjuvant

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Active, not recruiting

Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection

Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III

United States
Puma Biotechnology, Inc.

Completed

Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer (NEFERTT)

Breast Cancer

Spain, China, United States, Australia, Hong Kong, Malaysia, Korea, Republic of, Singapore, Belgium, Japan, India, France, Hungary, Romania, Italy, Bulgaria, Germany, Serbia, United Kingdom, South Africa, Canada, Israel, Taiwan, Switz... and more
AstraZeneca
Daiichi Sankyo

Active, not recruiting

A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer

Breast Cancer

United States, France, Italy, Spain, United Kingdom, Canada, India, Thailand, Vietnam, Bulgaria, Belgium, Switzerland, Germany, Brazil, Japan, Poland, China, Malaysia, Taiwan, Austria, Hungary, Australia, Singapore, Hong Kong, South Korea, Turkey (Türkiye)
Bristol-Myers Squibb

Completed

Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer (CheckMate 7FL)

Breast Cancer

China, Russian Federation, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czechia, Denmark, Finland, France, Germany, Hong Kong, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Portuga... and more
Northwestern University

Recruiting

Shockwave in Postoperative Breast Reconstruction Fibrosis

Fibrosis Breast

United States
University of Illinois at Chicago

Recruiting

MADRE (Mammograms Available Due to Research and Education) (MADRE)

Breast Cancer Screening

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training

Breast Cancer Survivors

United States
Brigham and Women's Hospital

Completed

Project 1: Self-Triage by 2D Full-field Digital Mammography or Synthetic Images

Breast Cancer Screening

United States
Perimeter Medical Imaging

Terminated

Intraoperative Use of an Optical Coherence Tomography (OCT) Imaging System to Guide Additional Margin Cavity Shaves in Breast Conserving Surgery (BCS)

Breast Cancer Female

United States
QT Ultrasound LLC
Analysis Group, Inc.

Suspended

Understanding Patient Experience and Preferences for the QT Scanner Compared to Mammography

Breast Cancer Screening

United States
SCRI Development Innovations, LLC

Completed

Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC

Metastatic Breast Cancer

United States
University of Wisconsin, Madison
National Cancer Institute (NCI)

Completed

Effectiveness of the CHESS eHealth Cancer Support Intervention in Population-based Care

Primary Breast Cancer

United States
Abramson Cancer Center of the University of Pennsylvania

Completed

Adherence to Aromatase Inhibitors: The Role of Partners

Breast Cancer Survivors

United States
TriHealth Inc.

Withdrawn

Comparison of Long vs. Short Acting Anesthesia for Improving Pain Management After Breast Biopsy

Pain Management After Breast Biopsy

United States
Ohio State University Comprehensive Cancer Center

Recruiting

Inspiratory Muscle Training in Obese Breast Cancer Survivors (IMOCS)

Obesity | Breast Cancer | Cancer Survivors

United States
University of California, Davis
Eli Lilly and Company; Celgene

Terminated

Abraxane and Alimta in Advanced Solid Tumors

Breast Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
Johns Hopkins University
National Institutes of Health (NIH); National Library of Medicine (NLM)

Completed

Evaluating Patient Information Prescriptions

Breast Neoplasms | Premature Birth

United States
Cylene Pharmaceuticals

Unknown

Dose-escalation Study of Oral CX-4945

Breast Cancer | Multiple Myeloma | Advanced Solid Tumors | Inflammatory Breast Cancer | Castleman's Disease

United States
American College of Radiology Imaging Network
National Cancer Institute (NCI)

Completed

Digital Mammography Screening Trial (ACRIN6652) (DMIST)

Breast Cancer

United States, Canada
Galena Biopharma, Inc.

Completed

Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence (PRESENT)

Breast Cancer With Low to Intermediate HER2 Expression

United States, United Kingdom, France, Israel, Germany, Canada, Russian Federation, Romania, Bulgaria, Czech Republic, Hungary, Poland, Ukraine
Memorial Sloan Kettering Cancer Center

Recruiting

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Non Small Cell Lung Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Metastatic Non-Small Cell Lung Carcinoma

United States
Breast Cancer Trials, Australia and New Zealand

Not yet recruiting

GDF-15 and Its Relationship With Treatment-related ADverse Events in Breast Cancer (GRADE)

Breast Cancer

United States, Japan, Australia
Rutgers, The State University of New Jersey
Ludwig Institute for Cancer Research

Recruiting

Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer (FITWISE)

Hormone Receptor-Positive Breast Cancer | HER2-Negative Breast Cancer

United States
Odonate Therapeutics, Inc.

Terminated

Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC (CONTESSA)

Breast Cancer

Korea, Republic of, United States, Spain, Canada, Singapore, Taiwan, Australia, Belgium, Thailand, Hungary, Germany, United Kingdom, France, Ukraine, Austria, Czechia, Italy, Poland, Russian Federation
Memorial Sloan Kettering Cancer Center
Icahn School of Medicine at Mount Sinai

Recruiting

Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients

Breast Cancer

United States
Abramson Cancer Center at Penn Medicine
American Heart Association

Active, not recruiting

Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer (CCT2)

Cardiovascular Diseases | Breast Cancer | Drug-Related Side Effects and Adverse Reactions | Cardiotoxicity

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery

Breast Cancer | Cardiac Toxicity

United States

Clinical Trials on Glabellar Crease in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations